Skip to Content

Ketamine Injection

Last Updated: June 1, 2020
Status: Current

Products Affected - Description
    • Ketamine injection, Hikma, 100 mg/mL, 5 mL vial, 10 count, NDC 00143-9509-10
    • Ketamine injection, Hikma, 50 mg/mL, 10 mL vial, 10 count, NDC 00143-9508-10
    • Ketamine injection, Mylan Institutional, 10 mg/mL, 20 mL vial, 10 count, NDC 67457-0181-20
    • Ketamine injection, Pfizer, 50 mg/mL, 10 mL vial, 10 count, NDC 00409-2053-10
Reason for the Shortage
    • Hikma did not provide a reason for the shortage.
    • Mylan Institutional did not provide a reason for the shortage.
    • Par has Ketalar available.
    • Pfizer has ketamine on shortage due to manufacturing delays.
Available Products
    • Ketalar injection, Par Pharmaceuticals, 10 mg/mL, 20 mL vial, 10 count, NDC 42023-0113-10
    • Ketalar injection, Par Pharmaceuticals, 100 mg/mL, 5 mL vial, 10 count, NDC 42023-0115-10
    • Ketalar injection, Par Pharmaceuticals, 50 mg/mL, 10 mL vial, 10 count, NDC 42023-0114-10
    • Ketamine injection, Mylan Institutional, 100 mg/mL, 10 mL vial, 10 count, NDC 67457-0108-10
    • Ketamine injection, Mylan Institutional, 50 mg/mL, 10 mL vial, 10 count, NDC 67457-0001-10
    • Ketamine injection, Pfizer, 100 mg/mL, 5 mL vial, 10 count, NDC 00409-2051-05

Estimated Resupply Dates

    • Hikma has ketamine 50 mg/mL 10 mL vials and 100 mg/mL 5 mL vials on back order and the company estimates a release date of late-June to early-July 2020.
    • Mylan Institutional has ketamine 10 mg/mL 20 mL vials on back order and the company estimates a release date of mid-June 2020.
    • Pfizer has ketamine 50 mg/mL 10 mL vials on back order and the company estimates a release date of November 2020.

Updated

Updated June 1, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. Created February 7, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2020, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide